Company Filing History:
1 out of 119 
1 out of 48 
Years Active: 2012
Title: Ulrich Möbius: Innovator in Tumor Treatment
Introduction
Ulrich Möbius is a notable inventor based in Gauting, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of tumors. His innovative work has led to the development of a specific anti-L1 antibody that holds promise for cancer therapy.
Latest Patents
Ulrich Möbius holds 1 patent related to his groundbreaking work. His patent, titled "Treatment of tumors using specific anti-L1 antibody," focuses on the anti-L1 monoclonal antibody 9.3 and its related antibodies or binding molecules. This invention is particularly relevant for its applications in tumor treatment, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Ulrich has worked with esteemed organizations such as the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts and Medigene AG. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in cancer research.
Collaborations
Ulrich has collaborated with notable colleagues, including Daniela Kelm and Peter Altevogt. These partnerships have enriched his research and expanded the impact of his innovations in the medical community.
Conclusion
Ulrich Möbius is a distinguished inventor whose work in tumor treatment exemplifies the intersection of innovation and medical research. His contributions continue to inspire advancements in cancer therapy and highlight the importance of collaboration in scientific discovery.